Gossamer Bio, Inc. (GOSS) Balance Sheet
GOSS balance sheet, 2025
December 31, 2025 · U.S. dollars$172.2M assets = $295.0M liabilities + −$122.8M equity
Liabilities exceed assets: shareholders’ equity is negative (−$122.8M).
Both columns are drawn to the same scale: what GOSS owns equals what it owes plus shareholders’ equity. Hover a block for its value.
GOSS financial health
Descriptive bands, not a rating. Fiscal 2025.
GOSS balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $60,0002016 | $172.2M2025 | +142.2%/yr | |
| Total liabilities | $183,0002016 | $295.0M2025 | +127.2%/yr | |
| Shareholders’ equity | −$123,0002016 | −$122.8M2025 | — | |
| Cash & short-term investments | $60,0002016 | $136.9M2025 | +136.1%/yr | |
| Total debt | $40,0002016 | $202.9M2025 | +158.0%/yr | |
| Net cash (debt) | $20,0002016 | −$66.0M2025 | −$66.0M | |
| Working capital | −$83,0002016 | $104.2M2025 | +$104.3M | |
| Book value per share | $32.902023 | −$42.982025 | — | |
| Current ratio | 0.422016 | 2.642025 | +2.22 | |
| Debt / equity | 0.112019 | 6.882024 | +6.77 | |
| Shares outstanding | 1.9M2023 | 2.9M2025 | +22.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
GOSS assets
GOSS liabilities and equity
GOSS debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
GOSS balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $136.9M | $294.5M | $296.4M | $255.7M | $325.2M | $512.6M | $401.8M | $228.7M | $315,000 | $60,000 |
| Cash & equivalents | $37.7M | $46.1M | $32.1M | $112.0M | $183.4M | $486.1M | $135.0M | $105.2M | $315,000 | $60,000 |
| Short-term investments | $99.2M | $248.4M | $264.3M | $143.7M | $141.8M | $26.6M | $266.7M | $123.4M | $0 | $0 |
| Receivables | $12.5M | $5.3M | $0 | $0 | $200,000 | $200,000 | $1.5M | $500,000 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | −$136,000 | $365,000 | −$1.5M | $0 | $0 | $0 |
| Other current assets | $18.2M | $10.0M | $10.1M | $6.2M | $6.5M | $9.1M | $7.6M | $2.8M | $130,000 | $0 |
| Total current assets | $167.6M | $309.9M | $306.5M | $261.9M | $331.8M | $522.3M | $409.3M | $232.0M | $445,000 | $60,000 |
| Property, plant & equipment (net) | $4.2M | $5.1M | $4.8M | $9.9M | $10.8M | $16.1M | $15.7M | $3.2M | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $408,000 | $283,000 | $618,000 | $680,000 | $1.1M | $1.0M | $1.6M | $4.3M | $0 | $0 |
| Total assets | $172.2M | $315.3M | $311.9M | $272.4M | $343.7M | $539.4M | $426.6M | $239.4M | $445,000 | $60,000 |
| Liabilities | ||||||||||
| Accounts payable | $6.0M | $2.3M | $5.5M | $1.5M | $3.2M | $7.5M | $956,000 | $2.2M | $97,000 | $40,000 |
| Short-term debt | $938,000 | $961,000 | $14.9M | $14.6M | $2.9M | $3.6M | $2.4M | — | — | — |
| Deferred revenue | $20.0M | $17.1M | — | — | — | — | — | — | — | — |
| Total current liabilities | $63.4M | $45.0M | $51.6M | $49.2M | $39.9M | $38.6M | $36.9M | $20.4M | $1.3M | $143,000 |
| Long-term debt | $198.5M | $197.5M | $197.4M | $207.7M | $179.1M | $172.4M | $28.5M | $0 | $6.0M | $40,000 |
| Lease obligations | $4.4M | $5.4M | $3.4M | $6.4M | $6.1M | $11.3M | $11.1M | — | — | — |
| Other long-term liabilities | $33.1M | $43.3M | $144,000 | $3.4M | $3.2M | $7.7M | $8.7M | $339.1M | $1,000 | $0 |
| Total liabilities | $295.0M | $285.8M | $249.1M | $260.4M | $222.2M | $218.7M | $74.1M | $359.5M | $7.3M | $183,000 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $24,000 | $23,000 | $23,000 | $10,000 | $8,000 | $8,000 | $7,000 | $2,000 | — | — |
| Retained earnings (deficit) | −$1.44B | −$1.27B | −$1.21B | −$1.03B | −$811.5M | −$577.5M | −$334.2M | −$153.9M | −$6.9M | −$123,000 |
| Accumulated other comprehensive income | −$5.1M | $1.2M | −$350,000 | −$574,000 | $45,000 | $599,000 | $258,000 | −$61,000 | — | — |
| Total shareholders' equity | −$122.8M | $29.5M | $62.8M | $12.1M | $121.5M | $320.7M | $352.5M | −$120.1M | −$6.9M | −$123,000 |
| Key figures | ||||||||||
| Total debt | $202.9M | $202.9M | $212.5M | $225.7M | $185.2M | $183.7M | $39.5M | — | $6.0M | $40,000 |
| Net cash (debt) | −$66.0M | $91.6M | $84.0M | $29.9M | $140.0M | $328.9M | $362.2M | — | −$5.7M | $20,000 |
| Working capital | $104.2M | $264.9M | $254.9M | $212.7M | $291.9M | $483.7M | $372.4M | $211.6M | −$821,000 | −$83,000 |
| Tangible book value | −$122.8M | $29.5M | $62.8M | $12.1M | $121.5M | $320.7M | $352.5M | −$120.1M | −$6.9M | −$123,000 |
| Book value per share | −$42.98 | $10.43 | $32.90 | — | — | — | — | — | — | — |
| Shares outstanding | 2.9M | 2.8M | 1.9M | — | — | — | — | — | — | — |
| Current ratio | 2.64 | 6.88 | 5.94 | 5.32 | 8.32 | 13.51 | 11.09 | 11.37 | 0.35 | 0.42 |
| Quick ratio | 2.36 | 6.66 | 5.74 | 5.19 | 8.16 | 13.27 | 10.92 | 11.23 | 0.25 | 0.42 |
| Debt / equity | — | 6.88 | 3.38 | 18.69 | 1.53 | 0.57 | 0.11 | — | — | — |
| Equity / assets | −71.3% | 9.4% | 20.1% | 4.4% | 35.3% | 59.4% | 82.6% | −50.2% | −1,542.0% | −205.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $57.0M | $99.2M | $136.9M | $180.2M | $212.9M | $257.9M | $294.5M | $327.0M | $354.5M | $244.4M | $296.4M | $328.9M |
| Cash & equivalents | $41.1M | $41.0M | $37.7M | $8.9M | $26.3M | $29.0M | $46.1M | $28.5M | $86.9M | $38.9M | $32.1M | $82.6M |
| Short-term investments | $15.9M | $58.2M | $99.2M | $171.3M | $186.6M | $228.9M | $248.4M | $298.6M | $267.6M | $205.5M | $264.3M | $246.3M |
| Receivables | $6.1M | $9.4M | $12.5M | $9.6M | $8.0M | $6.6M | $5.3M | $6.6M | $3.6M | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $9.6M | $16.0M | $18.2M | $14.1M | $15.0M | $11.0M | $10.0M | $10.6M | $12.8M | $10.9M | $10.1M | $12.6M |
| Total current assets | $72.7M | $124.5M | $167.6M | $204.0M | $235.9M | $275.5M | $309.9M | $344.3M | $370.9M | $255.3M | $306.5M | $341.5M |
| Property, plant & equipment (net) | $3.7M | $4.0M | $4.2M | $4.4M | $4.6M | $4.8M | $5.1M | $6.3M | $2.5M | $3.5M | $4.8M | $5.8M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $429,000 | $398,000 | $408,000 | $407,000 | $383,000 | $310,000 | $283,000 | $283,000 | $59,000 | $613,000 | $618,000 | $649,000 |
| Total assets | $76.9M | $128.9M | $172.2M | $208.8M | $240.9M | $280.6M | $315.3M | $350.9M | $373.4M | $259.4M | $311.9M | $347.9M |
| Liabilities | ||||||||||||
| Accounts payable | $6.0M | $10.8M | $6.0M | $1.1M | $1.9M | $3.4M | $2.3M | $3.1M | $1.0M | $2.7M | $5.5M | $1.3M |
| Short-term debt | $36.1M | $957,000 | $938,000 | $919,000 | $890,000 | $853,000 | $961,000 | $1.7M | $1.8M | $12.2M | $14.9M | $14.8M |
| Deferred revenue | $7.1M | $8.7M | $20.0M | $24.0M | $23.5M | $17.9M | $17.1M | $20.3M | $17.0M | — | — | −$3.2M |
| Total current liabilities | $137.8M | $56.5M | $63.4M | $62.1M | $53.6M | $48.2M | $45.0M | $51.1M | $45.2M | $35.8M | $51.6M | $42.3M |
| Long-term debt | $0 | $198.8M | $198.5M | $198.3M | $198.0M | $197.8M | $197.5M | $197.3M | $197.1M | $196.8M | $197.4M | $200.0M |
| Lease obligations | $3.9M | $4.2M | $4.4M | $4.6M | $4.8M | $5.0M | $5.4M | $6.3M | $1.8M | $2.6M | $3.4M | $4.2M |
| Other long-term liabilities | $33.1M | $35.1M | $33.1M | $30.8M | $35.4M | $40.9M | $43.3M | $48.4M | $49.7M | $0 | $144,000 | $992,000 |
| Total liabilities | $170.9M | $290.4M | $295.0M | $291.2M | $287.0M | $286.8M | $285.8M | $296.7M | $291.9M | $232.6M | $249.1M | $243.3M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $50,000 | $24,000 | $24,000 | $24,000 | $23,000 | $23,000 | $23,000 | $23,000 | $23,000 | $23,000 | $23,000 | $23,000 |
| Retained earnings (deficit) | −$1.47B | −$1.49B | −$1.44B | −$1.39B | −$1.34B | −$1.31B | −$1.27B | −$1.24B | −$1.20B | −$1.25B | −$1.21B | −$1.16B |
| Accumulated other comprehensive income | −$3.7M | −$4.0M | −$5.1M | −$5.1M | −$5.1M | −$824,000 | $1.2M | −$2.2M | −$518,000 | −$628,000 | −$350,000 | −$618,000 |
| Total shareholders' equity | −$94.0M | −$161.5M | −$122.8M | −$82.3M | −$46.1M | −$6.2M | $29.5M | $54.1M | $81.5M | $26.7M | $62.8M | $104.6M |
| Key figures | ||||||||||||
| Total debt | $39.1M | $202.9M | $202.9M | $202.9M | $202.8M | $202.8M | $202.9M | $203.6M | $198.9M | $209.1M | $212.5M | $215.8M |
| Net cash (debt) | $17.9M | −$103.7M | −$66.0M | −$22.7M | $10.1M | $55.1M | $91.6M | $123.4M | $155.6M | $35.3M | $84.0M | $113.1M |
| Working capital | −$65.1M | $68.0M | $104.2M | $141.9M | $182.3M | $227.3M | $264.9M | $293.2M | $325.7M | $219.4M | $254.9M | $299.2M |
| Tangible book value | −$94.0M | −$161.5M | −$122.8M | −$82.3M | −$46.1M | −$6.2M | $29.5M | $54.1M | $81.5M | $26.7M | $62.8M | $104.6M |
| Book value per share | −$22.88 | −$55.18 | −$43.34 | −$28.89 | −$16.23 | −$2.20 | $10.41 | $19.13 | $27.34 | $9.47 | $22.28 | $43.39 |
| Shares outstanding | 4.1M | 2.9M | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M | 3.0M | 2.8M | 2.8M | 2.4M |
| Current ratio | 0.53 | 2.20 | 2.64 | 3.28 | 4.40 | 5.71 | 6.88 | 6.74 | 8.21 | 7.13 | 5.94 | 8.07 |
| Quick ratio | 0.46 | 1.92 | 2.36 | 3.06 | 4.12 | 5.49 | 6.66 | 6.53 | 7.93 | 6.82 | 5.74 | 7.77 |
| Debt / equity | — | — | — | — | — | — | 6.88 | 3.76 | 2.44 | 7.82 | 3.38 | 2.06 |
| Equity / assets | −122.3% | −125.3% | −71.3% | −39.4% | −19.1% | −2.2% | 9.4% | 15.4% | 21.8% | 10.3% | 20.1% | 30.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 17, 2026); data from EODHD.
GOSS financial position
At the end of fiscal 2025 (December 31, 2025), Gossamer Bio had total assets of $172.2 million (down 45.4% from a year earlier), total liabilities of $295.0 million and shareholders' equity of -$122.8 million. It held $136.9 million in cash and short-term investments against $202.9 million of debt, net debt of $66.0 million. Its current ratio was 2.64. In the latest quarter (ended June 30, 2026) total assets were $76.9 million and equity -$94.0 million.
Related: GOSS income statement, GOSS cash flow statement, GOSS key metrics. See the GOSS stock overview for the latest quote and news.
GOSS balance sheet FAQ
What are Gossamer Bio's total assets?
Gossamer Bio reported total assets of $172.2 million at the end of fiscal 2025 (December 31, 2025), compared with $315.3 million a year earlier.
How much debt does Gossamer Bio have?
Gossamer Bio had $202.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does Gossamer Bio have?
Gossamer Bio held $136.9 million in cash and short-term investments at the end of fiscal 2025; with $202.9 million of debt that is net debt of $66.0 million.
What is Gossamer Bio's book value?
Gossamer Bio's shareholders' equity (book value) was -$122.8 million at the end of fiscal 2025, or −$42.98 per share.
What is Gossamer Bio's current ratio?
Gossamer Bio had current assets of $167.6 million and current liabilities of $63.4 million, a current ratio of 2.64 (it can cover its short-term obligations).